| 5.28 Data as of May 24 |  +0.05 / +0.96%Today’s Change | 4.20 Today|||52-Week Range 8.53 | -23.03% Year-to-Date |
| Previous close | 5.23 |
| Today’s open | 5.22 |
| Day’s range | 5.06 - 5.30 |
| Volume | 24,667 |
| Average volume (3 months) | 81,304 |
| Market cap | $178.1M |
| Dividend yield | -- |
| Earnings growth (last year) | +23.33% |
| Earnings growth (this year) | +4.35% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -1.32% |
| P/E ratio | NM |
| Price/Sales | 74.07 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| STMLStemline Therapeutic... | +0.03 | +0.19% |
| PRTAProthena Corporation... | +0.18 | +1.78% |
| SVASinovac Biotech Ltd | -0.04 | -1.19% |
| CORTCorcept Therapeutics... | +0.04 | +2.21% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $3.1M |
| Annual profit (last year) | -$7.6M |
| Net profit margin | -248.25% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Paul Averback, MD |
Chief Financial Officer, Secretary & Treasurer Roy M. Wolvin |
Corporate headquarters Saint-Laurent, Québec |
.
